Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events.
about
Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Activated recombinant factor V ...... cause serious adverse events.
@en
Activated recombinant factor V ...... cause serious adverse events.
@nl
type
label
Activated recombinant factor V ...... cause serious adverse events.
@en
Activated recombinant factor V ...... cause serious adverse events.
@nl
prefLabel
Activated recombinant factor V ...... cause serious adverse events.
@en
Activated recombinant factor V ...... cause serious adverse events.
@nl
P2860
P356
P1433
P1476
Activated recombinant factor V ...... cause serious adverse events.
@en
P2093
Margaret S Sozio
Naga Chalasani
P2860
P304
P356
10.1002/HEP.27363
P407
P577
2014-10-02T00:00:00Z